AMLX Financials
Amylyx Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$14.29
Market Cap
$1.59B
EPS
$-1.53
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$87.37M
Gross Profit
-
Operating Income
-
Net Income
$-301.74M
EPS (Diluted)
$-4.43
Balance Sheet Highlights
Total Assets
$193.63M
Total Liabilities
$28.87M
Shareholders Equity
-
Cash & Equivalents
$77.39M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-167.65M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
13594.6%
ROE
-0.6%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is AMLX revenue?
AMLX's most recent quarterly revenue was $87.37M. Annual revenue can be calculated by summing the four most recent quarters.
Is AMLX profitable?
AMLX reported a loss of $301.74M in the most recent quarter.
What is AMLX market cap?
AMLX has a market capitalization of $1.59B, making it a small-cap stock.
Does AMLX have debt?
View AMLX's balance sheet for debt information.
What is AMLX cash flow?
Cash flow data is available in the full financial statements.